[
Abstract]
[
Full Text PDF] （in Japanese / 2153KB）
[Members Only And Two Factor Auth.] J.Jpn. Surg. Soc.. 90(9): 1513-1516, 1989
Report on the annual meeting
St. Jude MEDICAL VALVE REPLACEMENT : CLINICAL EXPERIENCE WITH 1,039 PATIENTS
St. Jude Medical valve replacement was performed in 1,039 patients ; 320 had aortic (AVR), 543 mitral (MVR), and 176 had double valve replacement (DVR). There were 44 (4.2％) early deaths. Follow-up extended in 995 patients from 10 to 130 months, with a cumurative period of 2,730 patients-years. The overall survival rates of AVR, MVR, and DVR patients at 10 years were 60.5％, 89.6％, 90.3％ respectively. The linearized incidences of valve thrombosis, thromboembolism, anticoagulation-related hemorrhage, prosthetic valve endocarditis, and significant hemolysis were as follows : 0.11％/pt-yr, 1.33％/pt-yr, 0.04％/pt-yr, 0.18％/pt-yr, and 0.11％/pt-yr, respectively. There were no structural failure after 10 years follow-up. Reoperatin (explant and re-replacement or suture repair) was required in 10 patients. Seven of them had periprosthetic leakage, 2 had valve thrombosis, and one underwent reoperation because of a technical error. Actuarially over 98％ of patients were free of valve-related mortality at 10 years.
St. Jude Medical valve is an excellent alternative for use in the surgical treatment of valvular heart disease.
To read the PDF file you will need Adobe Reader installed on your computer.